ArticleBMC public health2025
Associations of child-to-adult body size change with risk of hypertension and metabolic dysfunction-associated steatotic liver disease: a population-based cohort study of 226,420 individuals.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationships between body size changes and the risk of hypertension and metabolic dysfunction-associated steatotic liver disease (MASLD) are still unclear. This study examined the independent and combined influences of child and adult body size on the risk of adulthood hypertension and MASLD.
methodsWe included 226,420 participants from the UK Biobank who were free of hypertension and liver diseases. Child-to-adult body size categories were identified based on self-reported childhood body size and measured BMI in adulthood. Cox proportional hazard regression models were applied to assess the associations between body size categories and the incidence of hypertension and MASLD. Mediation analyses to address the effect of anthropometric measures and metabolic risk factors were also performed.
resultsAfter a median follow-up of approximately 13 years, 28,662 individuals had developed hypertension (N = 27,624) and/or MASLD (N = 1,692). Low body size in childhood increased the risk of adulthood hypertension and MASLD, regardless of adult body size. Individuals with low child body size and high adult body size exhibited the highest risk for both hypertension (HR 2.01, P < 0.001) and MASLD (HR 3.28, P < 0.001). Individuals who had high child body size but average body size in adulthood had risks of the two diseases that were similar to those of persons who had an average body size consistently (all P > 0.05). Body size changes influenced hypertension through significant natural direct effects and indirect effects via anthropometric and metabolic factors, while their impact on MASLD was primarily mediated by these factors without significant direct effects.
conclusionsChildhood leanness exacerbates the risk of hypertension and MASLD in adulthood. Within the follow-up period, normal adult body size would mitigate the detrimental effects of childhood obesity. Thus, attention should be given to reinforcing weight management in children by implementing evidence-based strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.